Article Details

Psychedelic Therapeutics Market Hits USD 6.5 Bn by 2028| iX Biopharma, MAPS Public Benefit ...

Retrieved on: 2021-04-13 12:22:30

Tags for this article:

Click the tags to see associated articles and topics

Psychedelic Therapeutics Market Hits USD 6.5 Bn by 2028| iX Biopharma, MAPS Public Benefit .... View article details on hiswai:

Excerpt

Top Key Players: Celon Pharma; iX Biopharma; MAPS Public Benefit; MindMed; Janssen Pharmaceuticals; Jazz Pharmaceutical. The assessment report ...

Article found on: ksusentinel.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo